Mechanisms of Hepatic Heterogeneity and ATF6 Mediated Metabolic Dysfunction in AATD07/01/2022 - 06/30/2024 (PI)
Alpha-1 Foundation
Defining PiMZ AATD Liver Disease Susceptibility with CRISPR Targeted Syngeneic iPSCs07/01/2018 - 06/30/2021 (PI)
Alpha-1 Foundation
CRISPR-DIRECTED Editing Of Patient-iPSCs To Determine Genetic Contributors07/01/2016 - 06/30/2018 (Key Person / Fellow)
PI:
Andrew A. Wilson, MDAlpha-1 Foundation